Published in Ann Pharmacother on January 01, 2000
A global health elective course in a PharmD curriculum. Am J Pharm Educ (2014) 0.99
Survey of patient perceptions towards short-term mobile medical aid for those living in a medically underserved area of Swaziland. BMC Health Serv Res (2015) 0.78
[Not Available]. Can J Hosp Pharm (2015) 0.75
Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors. J Virol (1996) 3.39
Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors. J Virol (1997) 3.29
Mutational analysis of the interaction between CD4 and class II MHC: class II antigens contact CD4 on a surface opposite the gp120-binding site. Cell (1991) 1.53
The effect of poly(ADP-ribosyl)ation on native and H1-depleted chromatin. A role of poly(ADP-ribosyl)ation on core nucleosome structure. J Biol Chem (1989) 1.46
Modulation of chromatin superstructure induced by poly(ADP-ribose) synthesis and degradation. J Biol Chem (1986) 1.30
Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention. Br J Clin Pharmacol (2005) 1.29
In vitro characterization of a purified NS2/3 protease variant of hepatitis C virus. J Biol Chem (2001) 1.17
New methodology for specific inhalation challenges with occupational agents in powder form. Eur Respir J (1989) 1.12
Crystal structures of HIV-2 protease in complex with inhibitors containing the hydroxyethylamine dipeptide isostere. Structure (1995) 1.10
Novel Gag-Pol frameshift site in human immunodeficiency virus type 1 variants resistant to protease inhibitors. J Virol (1998) 1.07
Peptide-based inhibitors of the hepatitis C virus serine protease. Bioorg Med Chem Lett (1998) 1.03
Determination of kinetic rate constants for the binding of inhibitors to HIV-1 protease and for the association and dissociation of active homodimer. Biochemistry (1994) 1.00
Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitors. Bioorg Med Chem Lett (2000) 0.96
Immunoelectron microscopical distribution of poly(ADP-ribose)polymerase in the mammalian cell nucleus. Exp Cell Res (1988) 0.89
Automated analysis of DNA damage in the high-throughput version of the comet assay. Mutat Res (2010) 0.88
Production and characterization of monoclonal antibodies specific for the functional domains of poly(ADP-ribose) polymerase. Biochem Cell Biol (1986) 0.87
Studies on the C-terminal of hexapeptide inhibitors of the hepatitis C virus serine protease. Bioorg Med Chem Lett (1998) 0.87
Possible role of ADP-ribosylation of adenovirus core proteins in virus infection. Virus Res (1986) 0.86
Visualization of poly(ADP-ribose) synthetase associated with polynucleosomes by immunoelectron microscopy. Biochim Biophys Acta (1986) 0.86
Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structures. Proc Natl Acad Sci U S A (1993) 0.85
Solution structure of substrate-based ligands when bound to hepatitis C virus NS3 protease domain. J Biol Chem (1999) 0.85
A positive signal is transduced via surface CD4 molecules. Res Immunol (1989) 0.83
Microtube batch protein crystallization: applications to human immunodeficiency virus type 2 (HIV-2) protease and human renin. Proteins (1994) 0.82
Induction of sister-chromatid exchanges by AluI, DNase I, benzon nuclease and bleomycin in Chinese hamster ovary (CHO) cells. Mutat Res (1994) 0.82
High resolution crystal structures of recombinant human renin in complex with polyhydroxymonoamide inhibitors. J Mol Biol (1995) 0.80
NMR line-broadening and transferred NOESY as a medicinal chemistry tool for studying inhibitors of the hepatitis C virus NS3 protease domain. Bioorg Med Chem Lett (2000) 0.80
Enzymatic characterization of purified recombinant human renin. Biochem Cell Biol (1995) 0.79
2',6'-Dimethylphenoxyacetyl: a new achiral high affinity P(3)-P(2) ligand for peptidomimetic-based HIV protease inhibitors. J Med Chem (2000) 0.78
Potent HIV protease inhibitors containing a novel (hydroxyethyl)amide isostere. J Med Chem (1997) 0.78
Crystallographic studies on the binding modes of P2-P3 butanediamide renin inhibitors. J Biol Chem (1995) 0.76
Quantification of cytosolic steroid receptors in secretory and non-secretory epithelial cells of the canine prostate. J Steroid Biochem (1985) 0.75
The human renin infused rat: use as an in vivo model for the biological evaluation of human renin inhibitors. Can J Physiol Pharmacol (1999) 0.75
Kinetic analysis of attached growth nitrification in cold climates. Water Sci Technol (2009) 0.75
[Health needs and health care of adolescents at the Probation Services of the Montreal Metropolitan Center for Social Services]. Union Med Can (1981) 0.75
Correlation of chromosomal aberrations and sister chromatid exchanges in individual CHO cells pre-labelled with BrdU and treated with DNaseI or X-rays. Int J Radiat Biol (2002) 0.75
Influence of sodium butyrate on the induction of radiation-induced chromosomal aberrations and sister chromatid exchanges in Chinese hamster ovary (CHO) cells. Mutat Res (1999) 0.75
Time-resolved ligand exchange reactions: kinetic models for competitive inhibitors with recombinant human renin. J Med Chem (1995) 0.75